AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Legislators plan a confrontation with Gov. Glenn Youngkin over two of his highest-profile vetoes last year: bills for a state ...

Gov. Maura Healey signed two major healthcare reform bills Wednesday — one that looks to increase hospital oversight in the ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

The changes to Medicare’s prescription drug cap were set in motion by the Biden administration’s 2022 Inflation Reduction Act ...